The microRNA miR-210 is a signature of hypoxia. We found robust increase in the abundance of miR-210 (>100-fold) in activated T cells, especially in the T H 17 lineage of helper T cells. Hypoxia acted in synergy with stimulation via the T cell antigen receptor (TCR) and coreceptor CD28 to accelerate and increase Mir210 expression. Mir210 was directly regulated by HIF-1a, a key transcriptional regulator of T H 17 polarization. Unexpectedly, we identified Hif1a as a target of miR-210, which suggested negative feedback by miR-210 in inhibiting HIF-1a expression. Deletion of Mir210 promoted T H 17 differentiation under conditions of limited oxygen. In experimental colitis, miR-210 reduced the abundance of Hif1a transcripts and the proportion of cells that produced inflammatory cytokines and controlled disease severity. Our study identifies miR-210 as an important regulator of T cell differentiation in hypoxia, which can limit immunopathology.
T cell responses are usually studied in vitro at the atmospheric O 2 concentration of 21%. However, oxygen tensions in lymphoid tissues are markedly lower (<5%) than those found in peripheral arterial blood (13%) 1, 2 . Cells of the immune system are exposed to varying oxygen tensions in lymphoid organs 2 . T cells are activated during the recognition of antigens at inflammatory or tumor sites, both of which are hypoxic 2 . Moreover, hypoxic extracellular environments exist in healthy and diseased nonlymphoid tissues, including adipose tissue 3 , skin 4 and the gastrointestinal tract 5 . Therefore, activated T cells are dependent on an intracellular machinery that allows them to adapt to changes in oxygen tension and execute their functions in situ. The transcription factor HIF-1 mediates at least some of the required metabolic switches from oxidative phosphorylation to aerobic glycolysis in response to hypoxia 6 .
The HIF-1 complex consists of two subunits, HIF-1α and HIF-1β 7 . Under normoxic conditions, proline residues of HIF-1α are hydroxylated by prolyl hydroxylases, which promotes binding of HIF-1α to the von Hippel-Lindau E3 ligase complex, followed by ubiquitination and proteasomal degradation of HIF-1α 8, 9 . Hypoxic conditions inhibit the degradation of HIF-1α and lead to its stabilization. A further regulatory layer in cells that are not lymphocytes has been described; in intestinal epithelial cells, Hif1a is negatively regulated by the microRNA (miRNA) miR-155 during prolonged hypoxia 10 .
In addition to its involvement in the cellular response to hypoxia, HIF-1 has an important role in regulating differentiation into the T H 17 subset of helper T cells. T H 17 cells mount responses to extracellular bacterial and fungal infections in the intestine and the airways 11 . Despite the benefit of such immune responses, T H 17 cells can also serve immunopathological roles in experimental autoimmune settings as well as naturally occurring autoimmune settings, including collagen-induced arthritis, experimental autoimmune encephalomyelitis and inflammatory bowel disease (IBD) [12] [13] [14] . HIF-1 promotes T H 17 differentiation by directly inducing transcription of the gene encoding the transcription factor RORγt and subsequently acts together with RORγt to regulate downstream T H 17 cell-related genes and inhibit the differentiation of regulatory T cells (T reg cells) through an active process that targets the transcription factor Foxp3 for degradation 15 . In addition, deficiency in Hif1a in T cells diminishes the expression of glycolytic molecules and alters the dichotomy between T H 17 cells and T reg cells, which demonstrates that HIF-1α induces metabolic reprogramming and orchestrates the lineage differentiation of T cells 16 .
miRNAs are noncoding single-stranded RNAs of about 22 nucleotides that mediate the sequence-dependent post-transcriptional negative regulation of gene expression 17 . Various stresses, including hypoxia, regulate the expression and function of miRNA 18 . For example, a subset of miRNAs induced by hypoxia ('hypoxamiRs') contribute to the regulation of the broad spectrum of genes regulated by hypoxia. Among those miRNAs, miR-210 is the master 'hypoxamiR' and regulates a variety of cellular events in nonlymphoid tissues [19] [20] [21] [22] as well as B lymphocytes 23 .
Published work has identified miRNAs as pivotal regulators of the differentiation and function of helper T cells 24, 25 . Two genome-wide A r t i c l e s miRNA-profiling studies of activated T cells have revealed high expression of miR-210 after T cell stimulation 26, 27 . However, the regulation of Mir210 and the role of miR-210 in the activation and differentiation of T cells have not been studied before, to our knowledge.
RESULTS T cell activation robustly induces Mir210
Two independent studies of global miRNA expression profiling in lymphocytes have reported high expression of miR-210 in activated mouse T cells 26, 27 (Supplementary Fig. 1) . To address the expression pattern of miR-210 in more detail, we used real-time PCR (RT-PCR) to assess miR-210 expression after the stimulation of naive mouse CD4 + T cells with antibody to the invariant signaling protein CD3 (anti-CD3) and antibody to the costimulatory receptor CD28 (anti-CD28). Stimulation via the T cell antigen receptor (TCR) and CD28 led to an over-500-fold greater abundance of miR-210 in CD4 + T cells activated for 4 d than in unstimulated cells ( Fig. 1a) . In contrast to Il2 (encoding interleukin 2 (IL-2), which was rapidly upregulated by 12 h after stimulation, the abundance of miR-210 increased more slowly and reached its peak at 4 d after T cell activation ( Fig. 1a,d) , which suggested a possible regulatory role for miR-210 in later stages of T cell activation and function. We assessed whether induction of Mir210 also occurred in vivo in activated CD4 + T cells by two different approaches. First, we analyzed miR-210 expression in CD4 + T cells isolated from various lymphoid tissues, after homeostatic population expansion. For this, we sorted naive CD4 + T cells and adoptively transferred the cells into congenic mice deficient in recombinationactivating gene 2 (Rag2 −/− mice). After 3 weeks, we harvested cells from the spleen, inguinal lymph nodes, mesenteric lymph nodes, lungs and small intestine of the recipient mice. After their homeostatic population expansion, the transferred CD4 + T cells isolated from those tissues displayed a uniform, memory-like (CD44 hi CD62L − ) phenotype, and all of the samples had moderate upregulation of their expression of miR-155, an antigen stimulation-induced miRNA 28 ( Fig. 1b and Supplementary Fig. 2a ). The expression of miR-210 was also upregulated in those T cells, but unlike miR-155, miR-210 showed a distinct expression pattern, with much higher expression in CD4 + T cells isolated from hypoxic tissues such as the small intestine than in CD4 + T cells isolated from relatively normoxic tissues such as the lungs ( Fig. 1b and Supplementary Fig. 2a ). This suggested that miR-210 might have a more critical role in T cells residing in hypoxic sites. We also assessed the in vivo induction of Mir210 after immunization with ovalbumin (OVA). We isolated naive CD4 + T cells from OT-II mice (which have transgenic expression of a TCR specific for the OVA peptide of amino acids 323-339) and transferred those cells into congenic recipient mice, followed by challenge with OVA. The expression of miR-210 was markedly upregulated in the antigenresponsive T cells recovered relative to its expression in naive T cells ( Fig. 1c) . Similarly, Mir210 was robustly induced during the activation of CD8 + T cells both by in vitro stimulation and in a mouse model of infection with lymphocytic choriomeningitis virus ( Supplementary  Fig. 2b,c) . Collectively, these data suggested that T cell activation led to much higher miR-210 expression both in vitro and in vivo.
To study how Mir210 is regulated during T cell differentiation, we polarized naive CD4 + T cells into T H 1, T H 2, T H 17 and inducible T reg cells in vitro and measured the time-dependent appearance of miR-210 during the process of polarization. We observed the greatest increase in miR-210 in T H 17 cells ( Fig. 1d) . This suggested a 'preferential' role for miR-210 in the polarization or function of T H 17 cells.
CD28, not IL-2, signaling controls Mir210 expression
To determine whether CD28-mediated costimulation was involved in the upregulation of Mir210, we stimulated naive CD4 + T cells with anti-CD3 in the presence or absence of anti-CD28. The abundance of miR-210 was sixfold higher in samples costimulated with anti-CD28 than in samples stimulated with anti-CD3 alone ( Fig. 2a ). Since costimulation of CD28 is known to promote IL-2 production 29 , and the induction of Il2 transcripts preceded the induction of Mir210 (Fig. 1a) , we investigated whether CD28-mediated costimulation might indirectly induce Mir210 by assessing the abundance of miR-210 in CD4 + T cells from Il2 −/− Rag2 −/− DO11.10 mice (which have transgenic expression of an OVA-specific TCR). Whereas expression of the IL-2regulated miRNA miR-182 in IL-2-deficient CD4 + T cells was much lower than that in IL-2-sufficient cells after stimulation via the TCR 30 , IL-2 npg deficiency had no effect on miR-210 expression ( Fig. 2b) , which suggested that IL-2 signaling was not required for the induction of Mir210.
Since signaling via phosphatidylinositol-3-OH kinase (PI(3)K) is a major signaling pathway downstream of CD28 (ref. 31) , we addressed the requirement for PI(3)K in the induction of Mir210 through the use small-molecule inhibitors of enzymes involved in the PI(3)K signaling pathways. Whereas CP550690 (an inhibitor of the kinases Jak1 and Jak3) showed no inhibitory effect on the expression of miR-210 in T cells stimulated via TCR-CD28, both inhibitors of PI(3)K (LY294002 and GDC-0941) and inhibitors of the metabolic checkpoint kinase mTOR (rapamycin and MLN0128) potently suppressed miR-210 expression ( Fig. 2c) . Thus, the induction of Mir210 in activated T cells was dependent upon the PI(3)K-mTOR pathway.
Mir210 induction requires HIF-1a
To study the influence of hypoxia on the regulation of Mir210 in T lymphocytes, we compared the induction of Mir210 in resting primary CD4 + T cells under normoxic conditions (21% O 2 ) or hypoxic conditions (1% O 2 ) versus their counterparts stimulated with anti-CD3 and anti-CD28. Stimulation via the TCR in normoxia resulted in robust but delayed upregulation of miR-210 expression ( Fig. 3a) . The abundance of miR-210 increased only modestly in unstimulated T cells under hypoxic conditions ( Fig. 3a) , which suggested that in T cells, unlike results obtained for other cell types, hypoxia alone was insufficient to induce robust miR-210 expression. However, stimulated CD4 + or CD8 + T cells exhibited a rapid and markedly increase in the expression of miR-210 in hypoxia ( Fig. 3a and Supplementary  Fig. 2b ), which suggested a synergistic effect of stimulation via the TCR and hypoxia. Notably, that observation was specific for miR-210, since the abundance of miR-155 was not affected by oxygen tension during T cell activation ( Supplementary Fig. 2d ).
Since HIF-1α is the master regulator of hypoxic gene expression, we reasoned that HIF-1α might regulate Mir210 in T lymphocytes, as shown for other cell types 32 . Therefore, we compared the abundance of HIF-1α protein in resting CD4 + T cells under normoxic or hypoxic conditions versus their counterparts stimulated via the TCR. In both settings, stimulation via TCR resulted in the accumulation of HIF-1α by 24 h (Fig. 3b,c) . Consistent with the results obtained for miR-210 expression, hypoxia also led to a greater abundance of HIF-1α than obtained in normoxia on day 1 (Fig. 3b,c) . We also obtained similar results for activated CD8 + T cells ( Supplementary  Fig. 3a) . The observations that the expression of both miR-210 and HIF-1α was regulated by oxygen tension and that the expression of HIF-1α preceded the induction of Mir210 supported the proposal that HIF-1 acts upstream of miR-210. Furthermore, we found that CD28 deficiency resulted in much less HIF-1α protein in activated T cells ( Supplementary Fig. 3b ), which indicated that signaling via TCR-CD28 may induce Mir210 via HIF-1α.
To test that hypothesis, we studied Mir210 expression induced by TCR signaling under normoxic conditions in the presence or absence of HIF-1α. Whereas in HIF-1α-sufficient T cells, stimulation with anti-CD3 and anti-CD28 resulted in robust upregulation of both Hif1a and miR-210, the induction of Mir210 was markedly attenuated on a HIF-1α-deficient background ( Fig. 3d) , which indicated that HIF-1α was required for Mir210 induction in activated T cells. Deficiency in HIF-1α did not affect the global activation of CD4 + T cells, since miR-182 expression was largely unaffected by deletion of Hif1a (Fig. 3d) . Consequently, we reanalyzed a published data set obtained by analysis of T H 17-polarized cells by chromatin immunoprecipitation followed by deep sequencing 33 npg A r t i c l e s that after T cell activation, HIF-1α directly bound the promoter region of Mir210, with a binding peak at about 400 base pairs upstream of the Mir210 sequence ( Supplementary Fig. 3c ); this identified Mir210 as a direct downstream target of HIF-1α in activated T H 17 cells.
Whereas the abundance of HIF-1α protein was sustained until 2 d after stimulation in normoxia, HIF-1α markedly decreased between day 1 and day 2 under hypoxic conditions (Fig. 3b,c) . Under normoxic conditions, we detected the decrease in HIF-1α later, between day 2 and day 3 after stimulation via the TCR. In both cases, the decrease in HIF-1α correlated with an increase in the abundance of miR-210 ( Fig. 3b,c) , which raised the possibility that HIF-1α might be both an upstream regulator of Mir210 and a target of miR-210. We obtained similar results for CD8 + T cells activated under normoxic or hypoxic conditions ( Supplementary Figs. 2b and 3a) .
T cell-specific deletion of Mir210
To investigate the role of miR-210 in T cells, we crossed mice with loxP-flanked Mir210 alleles (Mir210 f/f mice) 34 with mice with transgenic expression of Cre recombinase driven by the T cell-specific Cd4 promoter (CD4-Cre), to ensure deletion of the loxP-flanked Mir210 alleles in T cells from the progeny of this cross (called 'Mir210 −/− mice' here). RT-PCR analysis indicated efficient deletion (>98%) of Mir210 in activated T cells from Mir210 −/− mice ( Supplementary  Fig. 4a ). Consistent with the low abundance of miR-210 in immature thymocytes ( Supplementary Fig. 4a ), miR-210 deficiency had little effect on T cell development ( Fig. 4a) . Moreover, wild-type and Mir210 −/− mice had similar a number and distribution of CD4 + T cells and CD8 + T cells in the periphery, and expression of the activation markers CD62L (L-selectin) and CD44 on peripheral CD4 + T cells was unaffected by deletion of Mir210 in 6-to 8-week-old mice ( Fig. 4b and data not shown). The development of natural T reg cells in the periphery seemed to be unaltered (Fig. 4b) . The proliferation of T cells in response to stimulation via TCR-CD28 or with the phorbol ester PMA plus ionomycin was also similar in wild-type and Mir210 −/− T cells ( Fig. 4c) . Therefore, miR-210 was not required for the development, homeostasis or proliferation of T cells.
Hif1a is a target of miR-210
To explore the role of miR-210 in T cell differentiation, we used in silico analysis to identify potential targets of miR-210. We identified potential miR-210 targets in mouse T cells by the following two-step selection process. First, we used four algorithms (Target scan, PicTar, miRDB and miRanda [35] [36] [37] [38] ) to predict miR-210 targets. We assigned all targets predicted by miRanda scores for an empirical probability of target inhibition through the use of mirSVR scores 39 and a stringent mirSVR score cutoff of −1.1. We combined that list with previously reported miR-210 targets 40 , which resulted in 69 potential miR-210 targets (Supplementary Fig. 4b and Supplementary Table 1 ). Next, we selected target genes expressed T cells, according to the database of the Immunological Genome Project, which resulted in 21 genes ( Supplementary Fig. 4b and Supplementary Table 1 ). We compared the expression of those genes by RT-PCR in wild-type and Mir210 −/− CD4 + T cells stimulated for 4 d with anti-TCR plus anti-CD28. Assuming that miR-210 deficiency would result in higher expression of direct miR-210 targets, we identified five candidate genes with expression more than twofold higher in Mir210 −/− CD4 + T cells than in their wild-type counterparts ( Fig. 5a and Supplementary Fig. 4b) . Two of those genes, Iscu and Ndufa4, have been reported as miR-210 targets 32, 41, 42 . Unexpectedly, among the miR-210 targets, Hif1a had the greatest upregulation (over fourfold) (Fig. 5a) .
To confirm that observation, we compared HIF-1α protein in resting wild-type or Mir210 −/− CD4 + T cells under normoxic or hypoxic conditions and in their counterparts stimulated via the TCR. In hypoxic conditions, we detected a considerable and sustained increase in the abundance of HIF-1α in activated Mir210 −/− T cells (Fig. 5b) . Moreover, we even detected a moderate increase in HIF-1α in Mir210 −/− T cells activated for 3 or 4 d in normoxic conditions (Fig. 5b) . Those results supported the proposal of Hif1a as a target of miR-210 and the idea that miR-210 adds an additional layer of regulation by curbing HIF-1α activity under hypoxia. The differences in the kinetics of the accumulation and degradation of HIF-1α in stimulated wild-type CD4 + T cells in normoxia or hypoxia (Fig. 3b,c) probably accounted for the finding that wild-type cells activated for 2 d in hypoxia had a slightly lower abundance of HIF-1α than that of cells activated in normoxia (Fig. 5b) . We also determined whether ectopic expression of miR-210 resulted in a lower abundance of Hif1a transcripts. To reconstitute miR-210 expression in Mir210 −/− CD4 + T cells activated via TCR-CD28, we transduced the cells with a bicistronic retrovirus expressing green fluorescent protein (GFP) and wild-type miR-210 or GFP and a miR-210 variant whose seed region was replaced by a scrambled control sequence (Fig. 5c) . We sorted GFP + (i.e., transduced) CD4 + T cells and found that Hif1a expression was markedly decreased by reconstitution with wild-type miR-210 but not by reconstitution with mutant miR-210 ( Fig. 5d) .
Hif1a has a noncanonical miR-210-binding site in its 3′ untranslated region (UTR) that contains one G:U 'wobble' at position 7 of the six-residue 'seed region' . Studies with high-throughput sequencing plus crosslinking immunoprecipitation have revealed that a sizeable fraction of miRNA-binding sites do not obey the 'seed-pairing rule' , which suggests that noncanonical sites are widespread 43, 44 . One of those studies also provided a T cell-specific genome-wide argonautebinding data set that enables analysis of the interactions of targets with all miRNAs expressed in activated T cells 44 . That data set showed a large peak of binding of argonaute to the Hif1a 3′ UTR at a site approximately 150 base pairs from the beginning of the 3′ UTR, where the predicted miR-210-binding site was located ( Supplementary  Fig. 5a ). That potential miR-210-binding site was highly conserved among multiple species (Supplementary Fig. 5b) , which emphasized its evolutionary importance. To determine whether miR-210 bound that site directly, we cloned the full-length Hif1a 3′ UTR (>1,800 nucleotides) into a luciferase reporter construct and cotransfected that reporter with miR-210 mimics into Mir210 −/− CD4 + T cells. 
A r t i c l e s
Cells transfected with a control luciferase reporter containing a tandem stretch of four consensus miR-210-binding sites (miR-210 sensor) together with miR-210 mimics exhibited much lower luciferase activity than did cells transfected with the same control luciferase reporter and control mimics (Fig. 5e) , which indicated that the miR-210 mimics did function in vivo. Notably, miR-210 expression also suppressed (by about 30%) the cotransfected Hif1a 3′ UTR reporter with only a single copy of the putative miR-210-binding site (Fig. 5e) . That amount of suppression of the Hif1a 3′ UTR by miR-210 was abolished by mutation of the miR-210-binding site (Fig. 5e) . Thus, our results identified Hif1a as a true target of miR-210.
miR-210 regulates T H 17 polarization under reoxygenation
Since HIF-1 promotes T H 17 differentiation 15, 16 , we investigated the potential role of miR-210 in T H 17 differentiation in vitro. We compared the efficiency of wild-type and Mir210 −/− naive T cells to differentiate into T H 17 cells in normoxia or in an oxygen-limited environment. Under hypoxic conditions (1% O 2 ), the population expansion of activated T cells was severely impaired (Supplementary Fig. 5c ).
Reoxygenation has been used to study T H 17 differentiation; this process is used to reflect the changes in O 2 concentration experienced by migrating T cells in vivo and involves the differentiation of T H 17 cells by a priming step under a low concentration of O 2 (5%) followed by transfer to normoxic conditions 45 (Supplementary Fig. 6a ). T H 17 differentiation was promoted more in reoxygenation conditions than in normoxia under T H 17skewing conditions that were suboptimal (0.2 ng/ml of IL-6), intermediate (2.0 ng/ml of IL-6) or maximal (20.0 ng/ml of IL-6) ( Fig. 6a) . We used a suboptimal concentration of IL-6 (0.2 ng/ml) in subsequent analyses, since it produced the largest increase in T H 17 differentiation (Fig. 6a) . Monitoring HIF-1α protein in T H 17 cells polarized under normoxia or reoxygenation, we detected more HIF-1α in cells skewed for 1 d under reoxygenation conditions, and a moderate increase in HIF-1α in cells polarized for 1, 2 or 3 d in normoxia (Fig. 6b) ; this suggested a critical role for HIF-1α in T H 17 differentiation in normoxic and reoxygenation conditions 15, 16, 45 . Consequently, CD4 + T cells polarized under reoxygenation conditions exhibited earlier and higher expression of miR-210 than that of their counterparts polarized under normoxic conditions (Fig. 6c) , and this was associated with a rapid decrease in HIF-1α between day 1 and day 2 (Fig. 6b,c) . We obtained similar results for activated T cells in nonpolarizing conditions (Supplementary Fig. 6b,c) . Notably, the greater T H 17 differentiation under reoxygenation than in normoxia was diminished by about 50% in Hif1a f/+ CD4-Cre T cells and was abolished in Hif1a f/f CD4-Cre T cells (Fig. 6d) , which indicated that HIF-1α was a limiting factor for T H 17 differentiation under reoxygenation conditions. Whereas deficiency in miR-210 had subtle effects on T H 17 differentiation under normoxic conditions, deletion of Mir210 resulted in a much greater proportion of T H 17 cells under reoxygenation, especially when we used low or intermediate concentrations of IL-6 ( Fig. 7a,b) . By comparison of wild-type and Mir210 −/− CD4 + T cells that were T H 17 polarized under reoxygenation conditions, we observed that the abundance of Hif1a transcripts and HIF-1α protein was greater in Mir210 −/− cells than in their wild-type counterparts (Fig. 7c,d) . The greater abundance of HIF-1α was associated with substantial upregulation of genes encoding key regulators of the glycolytic pathway (Fig. 7e) , which promote T H 17 differentiation 16 . That correlated well with higher expression of T H 17 signature genes, including Il17a, Il17f, Rorc and Il23r (Fig. 7f) . Notably, the observed increase in lineage differentiation under reoxygenation conditions and the further polarization by deletion of Mir210 applied exclusively to the T H 17 subset (Supplementary Fig. 6d,e) . Fig. 6f) , consistent with the diminished T H 17 differentiation under those conditions (Fig. 6a) . In contrast, wild-type CD4 + T cell samples skewed under reoxygenation conditions had a lower proportion of Foxp3 + cells (Supplementary Fig. 6f ), which correlated well with their enhanced T H 17-differentiation potential ( Fig. 6a ) and greater abundance of HIF-1α ( Fig. 6b) . Deletion of Mir210, which resulted in a further increase in the expression of HIF-1α protein under reoxygenation (Fig. 7d) , caused a further decrease in Foxp3 + cells (Supplementary Fig. 6f) .
To substantiate the proposal that miR-210 attenuated T H 17 differentiation by targeting Hif1a, we generated Mir210 −/− Hif1a f/+ mice and compared the T H 17-polarization potential of their naive T cells in normoxia or under reoxygenation with that of naive T cells from wild-type or Mir210 −/− mice. In confirmation of our results presented above, the enhanced T H 17 differentiation under reoxygenation caused by deficiency in miR-210 was considerably suppressed in Mir210 −/− Hif1a f/+ T cells (Fig. 7a) . This indicated that miR-210 regulated T H 17 polarization mainly by targeting Hif1a.
miR-210 controls IBD severity
The gut is a hypoxic environment 5 and contains a large proportion of IL-17A-producing cells 15 . To investigate whether miR-210 influenced the differentiation of T H 17 cells in vivo, we used an IBD model of colitis, in which the adoptive transfer of purified naive T cells causes weight loss in the lymphopenic recipient mice. For this, we obtained naive T cells from wild-type or Mir210 −/− (CD45.2 + ) mice, depleted those cell samples of T reg cells, then transferred them into Rag2 −/− (CD45.1 + ) mice. At 5 weeks after T cell transfer, wild-type T cells from the lamina propria had a much greater abundance of miR-210 than did naive T cells (Fig. 8a) . Consistent with the results obtained with the in vitro reoxygenation model, we found higher expression of Hif1a transcripts and HIF-1α protein in Mir210 −/− intestinal T cells in vivo than in their wild-type counterparts (Fig. 8a,b) . In contrast, splenic T cells isolated from the same mice had not upregulated their expression of HIF-1α protein (Fig. 8b) . Both groups (the control mice given wild-type (CD45.2 + ) T cells and the mice given Mir210 −/− (CD45.2 + ) T cells) began to lose body weight about 3-4 weeks after T cell transfer (Fig. 8c) . However, mice reconstituted with Mir210 −/− T cells exhibited substantially more weight loss, associated with more mucosal infiltration of leukocytes ( Fig. 8c,d) . Moreover, the mice given Mir210 −/− T cells had a greater ratio of weight to length for the colon, which correlated with worse histopathological scores (Fig. 8e) , evidence of more severe disease in the absence of miR-210. We measured the frequency of IL-17A-producing cells among CD4 + T cells isolated from the lamina propria of the recipient mice that exhibited weight loss 5.5 weeks after transfer and observed a much greater proportion of IL-17A + T cells in the mice given Mir210 −/− T cells (Fig. 8f) , which indicated that miR-210 controlled T H 17 differentiation in vivo. Furthermore, mice given Mir210 −/− T cells had greater proportion of cells expressing both IL-17A and interferon-γ (IL-17A + IFN-γ + cells) and IFN-γ + cells (Fig. 8f) , which indicated that miR-210 deficiency may also facilitate the conversion of T H 17 cells into T H 1-like cells. Collectively, these results supported the proposal of an important role for miR-210 in controlling T H 17 differentiation and the development of immunopathology in vivo. 
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A r t i c l e s DISCUSSION Two independent global miRNA-expression-profiling studies of lymphocytes have shown induction of miR-210 expression in effector T cells 26, 27 . Our studies here supported and extended those findings by suggesting a role for miR-210 in regulating the T H 17 lineage. We found that stimulation via the TCR led to robust induction of Mir210 in T cells under normoxic conditions. Moreover, hypoxia-challenged and antigen-stimulated T cells exhibited a more rapid and increased induction of Mir210 than did their unchallenged, unstimulated counterparts, which suggested that multiple signals were required for optimal Mir210 induction. Signals provided by antigens and costimulatory stimulation acted in synergy with signals provided by the hypoxic environment. Cells of the immune system encounter rapid changes in oxygen tension as they develop and migrate into various compartments of the body 46 . Therefore, a hypoxia-mediated signal for the proper induction of Mir210 would represent an additional layer of regulation for miRNAs critical in the immune system. Mir210 is fully induced only when T cells are activated at inflammatory sites or in cancerous tissues, both of which are considered hypoxic 47 . What might be a possible biological function of this HIF-1α-induced miRNA under hypoxic conditions? Not only was the expression of miR-210 upregulated by HIF-1α, but also miR-210 negatively regulated the abundance of Hif1a transcripts and HIF-1α protein in peripheral T cells; this has provided the first example, to our knowledge, of the 'desensitization' of HIF-1 activity by an miRNA in lymphocytes under hypoxic conditions. In contrast to normoxia, hypoxic conditions inhibit the degradation of HIF-1α and lead to its stabilization 8, 9 . However, the mechanism by which HIF-1α activity is turned off to prevent its excess activation in hypoxia has remained obscure. Two principal mechanisms have been proposed. First, although the hydroxylation activity of prolyl hydroxylases is limited in hypoxia, the HIF-1α-driven increase in expression of the prolyl hydroxylases PHD2 and PHD3 under hypoxic conditions may compensate for the loss of their activity and thus represents a negative-feedback loop that targets HIF-1α expression at the protein level [48] [49] [50] . Second, hypoxia-induced miR-155 directly targets Hif1a in intestinal epithelial cells, desensitizing HIF-1 activity at the transcript level 10 . However, we found that miR-155 was not regulated by hypoxia in human or mouse T cells and suggest that the 'hypoxamiR' miR-210 acts to specifically negatively regulate HIF-1α activity in T cells at later stages of activation.
The priming of naive T cells under O 2 -limited conditions (5% O 2 ) results in a greater abundance of HIF-1α protein and thereby accelerates T H 17 differentiation 45 . T cell-specific deletion of von Hippel-Lindau protein results in a greater abundance of HIF-1α and further increases T H 17 differentiation under reoxygenation conditions 45 . We found high HIF-1α-induced expression of Mir210 in T H 17 cells and showed that miR-210 directly 'suppressed' the abundance of Hif1a transcripts. Therefore, miR-210 seemed to have a role in feedback inhibition that curbed HIF-1 activity in T cells under hypoxia and consequently restrained T H 17 differentiation and the associated immunopathology. That was consistent with the lower Hif1a expression in response to ectopic expression of miR-210 and marked upregulation of the expression of Hif1a mRNA and HIF-1α protein in activated Mir210 −/− T cells. That effect was most evident under reoxygenation conditions in vitro and in hypoxic environments in vivo, which suggested that miR-210 serves its most important 'tuning' role in low-oxygen conditions.
Consistent with the finding that many models with knockout of miRNA develop altered phenotypes only under stress conditions 51 , Mir210 −/− T cells showed enhanced T H 17 polarization under reoxygenation but not in normoxia. Low oxygen tension increased the HIF-1α-miR-210 regulatory feedback loop in two ways. First, hypoxia acted in synergy with stimulation via TCR-CD28 to prompt more rapid and robust induction of Mir210, which then led to more profound negative regulation of the expression of Hif1a mRNA; that resulted in curbed HIF-1α activity in hypoxia. Therefore, we have identified miR-210 as a crucial regulator of HIF-1 activity and T H 17 differentiation in low-oxygen conditions, a finding further confirmed by our IBD studies.
HIF-1α has been suggested as a potential therapeutic target for the treatment of a variety of T H 17 cell-mediated autoimmune diseases 15 . Our in vitro and in vivo studies demonstrated that miR-210 was a potent regulator of Hif1a mRNA and HIF-1α protein in T cells under hypoxic conditions. Therefore, targeting Hif1a by administrating miR-210 mimics in vivo might be an effective therapeutic strategy for T H 17 cell-dependent autoimmune diseases.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
